PDSB · PDS Biotechnology Corp
AI read · Neutral
The AI's read
The new directors bring experience in drug development, biotech leadership, and business deals. That may help the board. But the filing does not explain the 4 departures, and says they were not caused by disagreements with the company. One board opening remains, and the filing reports no business change, so this board change alone does not point clearly up or down.